Showing results (1411-1420 of 3,400) with videos related to
Sort By:
Pageof 340
Eclinicalmedicine|April 25, 2023
Corrigendum to "The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis"Lauren L O'Mahoney, Ash Routen, Clare Gillies, et al.Eclinicalmedicine|August 25, 2020
A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomesRabail Chaudhry, George Dranitsaris, Talha Mubashir, et al.Eclinicalmedicine|April 3, 2023
Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept studyLizeth Cifuentes, Wissam Ghusn, Fauzi Feris, et al.Eclinicalmedicine|April 3, 2023
Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective studyYuHong Huang, Teng Zhu, XiaoLing Zhang, et al.Eclinicalmedicine|April 27, 2021
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trialJesper D Gunst, Nina B Staerke, Marie H Pahus, et al.Eclinicalmedicine|August 18, 2025
Management of Clostridioides difficile infection in patients with haematological malignancies and after cellular therapy: guidelines from 10th European Conference on Infections in Leukaemia (ECIL-10)Malgorzata Mikulska, Christine Robin, Dionysios Neofytos, et al.Eclinicalmedicine|August 12, 2025
Development and validation of a conventional MRI-based model to predict cerebral palsy in infants (aged 6-24 months) with periventricular white matter injury: a multicentre, retrospective cohort studyTingting Huang, Jie Zheng, Heng Liu, et al.Eclinicalmedicine|August 18, 2025
Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I studyZhengfu Fan, Jin Wang, Dan Liu, et al.Eclinicalmedicine|August 18, 2025
Quality of antidiabetic medicines in 13 sub-Saharan African countries: a cross-sectional surveyMarie Antignac, Roland N'Guetta, Philippe Henri Secretan, et al.Eclinicalmedicine|August 12, 2025
Factors influencing the prevalence and death rate of COPD: a pan-database ecological study covering 201 countries and regions from 1990 to 2021Zihui Wang, Wenhan Cao, Zhixuan You, et al.Pageof 340